229 related articles for article (PubMed ID: 11095436)
1. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo.
Nagayama Y; Yokoi H; Takeda K; Hasegawa M; Nishihara E; Namba H; Yamashita S; Niwa M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4081-6. PubMed ID: 11095436
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic usefulness of wild-type p53 gene introduction in a p53-null anaplastic thyroid carcinoma cell line.
Narimatsu M; Nagayama Y; Akino K; Yasuda M; Yamamoto T; Yang TT; Ohtsuru A; Namba H; Yamashita S; Ayabe H; Niwa M
J Clin Endocrinol Metab; 1998 Oct; 83(10):3668-72. PubMed ID: 9768682
[TBL] [Abstract][Full Text] [Related]
3. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
[TBL] [Abstract][Full Text] [Related]
5. Gadd45gamma expression is reduced in anaplastic thyroid cancer and its reexpression results in apoptosis.
Chung HK; Yi YW; Jung NC; Kim D; Suh JM; Kim H; Park KC; Kim DW; Hwang ES; Song JH; Ku BJ; Han HJ; Ro HK; Kim JM; Shong M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3913-20. PubMed ID: 12915687
[TBL] [Abstract][Full Text] [Related]
6. Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated Cre/loxP system.
Nagayama Y; Nishihara E; Namba H; Yokoi H; Hasegawa M; Mizuguchi H; Hayakawa T; Hamada H; Yamashita S; Niwa M
Cancer Gene Ther; 2001 Jan; 8(1):36-44. PubMed ID: 11219492
[TBL] [Abstract][Full Text] [Related]
7. Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer.
Barzon L; Bonaguro R; Castagliuolo I; Chilosi M; Gnatta E; Parolin C; Boscaro M; Palù G
J Clin Endocrinol Metab; 2002 Nov; 87(11):5304-11. PubMed ID: 12414907
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis and tumorigenesis, and induction of dormancy by p53 in a p53-null thyroid carcinoma cell line in vivo.
Nagayama Y; Shigematsu K; Namba H; Zeki K; Yamashita S; Niwa M
Anticancer Res; 2000; 20(4):2723-8. PubMed ID: 10953350
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model.
Li Z; Rakkar A; Katayose Y; Kim M; Shanmugam N; Srivastava S; Moul JW; McLeod DG; Cowan KH; Seth P
Gene Ther; 1998 May; 5(5):605-13. PubMed ID: 9797864
[TBL] [Abstract][Full Text] [Related]
10. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
11. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies.
Grace MJ; Xie L; Musco ML; Cui S; Gurnani M; DiGiacomo R; Chang A; Indelicato S; Syed J; Johnson R; Nielsen LL
Am J Pathol; 1999 Dec; 155(6):1869-78. PubMed ID: 10595917
[TBL] [Abstract][Full Text] [Related]
12. Treatment of human thyroid carcinoma cells with the g47delta oncolytic herpes simplex virus.
Wang JN; Xu LH; Zeng WG; Hu P; Rabkin SD; Liu RR
Asian Pac J Cancer Prev; 2015; 16(3):1241-5. PubMed ID: 25735362
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947.
Libertini S; Iacuzzo I; Perruolo G; Scala S; Ieranò C; Franco R; Hallden G; Portella G
Clin Cancer Res; 2008 Oct; 14(20):6505-14. PubMed ID: 18927290
[TBL] [Abstract][Full Text] [Related]
15. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus-mediated suicide gene/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter.
Braiden V; Nagayama Y; Iitaka M; Namba H; Niwa M; Yamashita S
Endocrinology; 1998 Sep; 139(9):3996-9. PubMed ID: 9724055
[TBL] [Abstract][Full Text] [Related]
17. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A
Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742
[TBL] [Abstract][Full Text] [Related]
18. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ
Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938
[TBL] [Abstract][Full Text] [Related]
19. A histone deacetylase inhibitor enhances killing of undifferentiated thyroid carcinoma cells by p53 gene therapy.
Imanishi R; Ohtsuru A; Iwamatsu M; Iioka T; Namba H; Seto S; Yano K; Yamashita S
J Clin Endocrinol Metab; 2002 Oct; 87(10):4821-4. PubMed ID: 12364480
[TBL] [Abstract][Full Text] [Related]
20. p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.
Vollmer CM; Ribas A; Butterfield LH; Dissette VB; Andrews KJ; Eilber FC; Montejo LD; Chen AY; Hu B; Glaspy JA; McBride WH; Economou JS
Cancer Res; 1999 Sep; 59(17):4369-74. PubMed ID: 10485485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
